Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study

H. I. Scher, A. Anand, D. Rathkopf, J. Shelkey, M. J. Morris, D. C. Danila, S. Larson, J. Humm, M. Fleisher, C. L. Sawyers, T. M. Beer, J. Alumkal, C. S. Higano, E. Y. Yu, M. E. Taplin, E. Efstathiou, D. Hung, M. Hirmand, L. Seely

    Research output: Contribution to journalArticlepeer-review

    844 Scopus citations

    Fingerprint Dive into the research topics of 'Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study'. Together they form a unique fingerprint.

    Medicine & Life Sciences